Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Novartis
Company Monitoring Page for Novartis
latest headlines for company on cafepharma
Amid major restructuring, Novartis CEO Narasimhan’s 2022 pay fell by more than a quarter
Fierce Pharma
Wed, 03/8/23 - 09:51 am
Tags:
Novartis
,
Pharma CEOs
,
Vas Narasimhan
,
executive pay
,
restructuring
Novartis ready to head for deep space with Voyager after a year 'kicking the tires'
Fierce Biotech
Mon, 03/6/23 - 11:41 am
Tags:
Novartis
,
Voyager Therapeutics
Novartis takes step toward expanding supply of in-demand cancer drug
Biopharma Dive
Sun, 03/5/23 - 03:09 pm
Tags:
Novartis
,
Pluvicto
,
prostate cancer
Spotlight – What is next in Nash
EP Vantage
Fri, 03/3/23 - 10:02 am
Tags:
NASH
,
clinical trials
,
89Bio
,
Arrowhead Pharmaceuticals
,
Can-Fite BioPharma
,
Ewopharma
,
Hepagene Therapeutics
,
JNJ
,
Ligand Pharmaceuticals
,
Madrigal Pharmaceuticals
,
Merck
,
NGM Biopharmaceuticals
,
NorthSea Therapeutics
,
Novartis
,
Sagimet Biosciences
,
Terns Pharmaceuticals
,
Viking Therapeutics
Go or no go? Vaccines and neurology up for discussion
EP Vantage
Tue, 02/28/23 - 11:05 am
Tags:
FDA
,
Acadia Pharmaceuticals
,
Apellis Pharmaceuticals
,
AstraZeneca
,
Biogen
,
Biomarin
,
Cidara Therapeutics
,
Emergent BioSolutions
,
GSK
,
Incyte
,
Ionis Pharmaceuticals
,
Melinta Therapeutics
,
Mundipharma
,
Novartis
,
Pfizer
,
Pharming
,
Regeneron
,
Roche
,
vaccines
,
RSV
,
ALS
,
COVID-19
Fulcrum's clinical hold caps off tough week for sickle cell drug development
Fierce Biotech
Sun, 02/26/23 - 10:20 pm
Tags:
Fulcrum Therapeuticsl
,
FDA
,
sickle cell disease
,
clinical trials
,
FDX-6058
,
Novartis
,
Sangamo
,
Graphite Bio
Novartis backs away from NASH, furthering its research revamp
BioPharma Dive
Sun, 02/26/23 - 10:16 pm
Tags:
Novartis
,
NASH
,
Pliant Therapeutics
,
PLN-1474
Novartis Drops SCD Gene Therapy Program with Intellia
BioSpace
Fri, 02/24/23 - 09:03 am
Tags:
Novartis
,
sickle cell disease
,
Intellia Therapeutics
,
CRISPR
,
gene editing
Novartis, Roche avoid $475M antitrust fine in French appeals court
Fierce Pharma
Mon, 02/20/23 - 12:57 pm
Tags:
Novartis
,
Roche
,
antitrust
,
Lucentis
Novartis loses $940M arbitration case against Mitsubishi Chemical over Gilenya royalties
Fierce Pharma
Mon, 02/20/23 - 12:42 pm
Tags:
Novartis
,
Mitsubishi Chemical
,
multiple sclerosis
,
MS
,
Supreme Court
,
legal
,
patents
,
Gilenya
Sandoz files biosimilar of Amgen osteoporosis drug in US
Pharmaphorum
Tue, 02/7/23 - 12:22 pm
Tags:
Sandoz
,
Novartis
,
biosimilars
,
osteoporosis
,
Prolia
,
Xgeva
,
FDA
Novartis CEO, as incoming PhRMA chair, outlines 3 priorities for pharma after IRA setback
Fierce Pharma
Wed, 02/1/23 - 10:22 pm
Tags:
Novartis
,
Vas Narasimhan
,
PhRMA
,
Inflation Reduction Act
,
PBMs
,
small molecule drugs
Novartis Reports Mixed Bag Q4 Earnings, Forecasts Higher Sales, Profits Ahead Of Sandoz Spin-Off
Yahoo/Benzinga
Wed, 02/1/23 - 10:39 am
Tags:
Novartis
,
earnings
,
Sandoz
Novartis' approved sickle cell disease drug fails to beat placebo in PhIII
Endpoints
Sun, 01/29/23 - 01:23 pm
Tags:
Novartis
,
sickle cell disease
,
Adakveo
,
clinical trials
Anthos doubles down on its novel blood thinner
EP Vantage
Fri, 01/27/23 - 10:34 am
Tags:
Anthos
,
Novartis
,
Factor XI inhibitor
,
bloodthinners
,
abelacimab
Could This Be Novartis' Next Blockbuster Medicine?
Motley Fool
Fri, 01/27/23 - 10:27 am
Tags:
Novartis
,
iptacopan
,
PNH
In a win for Regeneron, Novartis' syringe for AMD drug declared 'unpatentable'
Endpoints
Thu, 01/26/23 - 05:05 pm
Tags:
Regeneron
,
Novartis
,
Eylea
,
drug delivery
,
patents
,
Lucentis
After years of back-and-forth, Gilead's CAR-T Yescarta sways England's cost watchdog NICE
Fierce Pharma
Thu, 01/26/23 - 10:40 am
Tags:
Gilead Sciences
,
CAR-T
,
Yescarta
,
UK
,
NICE
,
Kite Pharma
,
Novartis
,
blood cancer
Sandoz signs deal for antifungal from Astellas in buff-up of anti-infectives portfolio
Endpoints
Wed, 01/25/23 - 10:44 am
Tags:
Sandoz
,
Novartis
,
Astellas
,
antifungals
,
Mycamine
,
generics
Novartis petitions Supreme Court in effort to 'vigorously defend' Gilenya patent
Endpoints
Tue, 01/24/23 - 06:18 pm
Tags:
Novartis
,
Supreme Court
,
Gilenya
,
patents
,
generics
,
multiple sclerosis
,
MS
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.